Literature DB >> 20705374

Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes.

Pei-Hsuan Tsai1, Jun-Jen Liu, Wan-Chun Chiu, Man-Hui Pai, Sung-Ling Yeh.   

Abstract

BACKGROUND & AIMS: Glutamine (Gln) is known to have immunomodulatory effects. Previous studies reported that Gln promotes insulin secretion in type 2 diabetes. However, the effects of Gln on insulin-deficient type 1 diabetes are not clear. This study investigated the effects of dietary Gln supplementation on adhesion molecule expression and oxidative damage in type 1 diabetic mice.
METHODS: There were 1 normal control (NC) group and 2 diabetic groups in this study. Mice in the NC group were fed a regular chow diet. One diabetic group (DM) was fed a common semipurified diet while the other diabetic group received a diet in which part of the casein was replaced by Gln (DM-Gln), which provided 25% of the total amino acid nitrogen for 6 wk. Diabetes was induced by an intraperitoneal injection of streptozotocin at a dose of 150 mg/kg body weight. Blood samples and the liver and kidneys of the animals were collected at the end of the study for further analysis.
RESULTS: Plasma glucose, fructosamine contents and adhesion molecule expressions were significantly higher in the diabetic groups than in the NC group. The DM group had higher leukocyte CD11a/CD18 expression. In diabetic mice, nitrotyrosine concentrations and myeloperoxidase activities were higher and the reduced to oxidized glutathione ratio was lower in liver and/or kidney. These alterations were not found in diabetic mice supplemented with Gln.
CONCLUSIONS: These results suggest that supplemental dietary Gln increased the antioxidant potential and consequently decreased leukocyte adhesion molecule expression and oxidative stress in organs of mice with type 1 diabetes.
Copyright © 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705374     DOI: 10.1016/j.clnu.2010.07.005

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  12 in total

1.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

2.  L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats.

Authors:  Renata Virginia Fernandes Pereira; Eleandro Aparecido Tronchini; Cristiano Massao Tashima; Eder Paulo Belato Alves; Mariana Machado Lima; Jacqueline Nelisis Zanoni
Journal:  Dig Dis Sci       Date:  2011-06-28       Impact factor: 3.199

3.  Effects of Ezetimibe, Simvastatin, and their Combination on Inflammatory Parameters in a Rat Model of Adjuvant-Induced Arthritis.

Authors:  Carmem Patrícia Barbosa; Lívia Bracht; Franciele Queiroz Ames; Francielli Maria de Souza Silva-Comar; Rafael Prizon Tronco; Ciomar Aparecida Bersani-Amado
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

4.  Is L-glutathione more effective than L-glutamine in preventing enteric diabetic neuropathy?

Authors:  Catchia Hermes-Uliana; Cynthia Priscilla do Nascimento Bonato Panizzon; Aline Rosa Trevizan; Camila Caviquioli Sehaber; Francielle Veiga Ramalho; Heber Amilcar Martins; Jacqueline Nelisis Zanoni
Journal:  Dig Dis Sci       Date:  2013-12-27       Impact factor: 3.199

5.  Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.

Authors:  Sachin L Badole; Swapnil M Chaudhari; Pranita P Bagul; Sagar P Mahamuni; Rekha D Khose; Anuja C Joshi; Chandrashekhar G Raut; Anand A Zanwar
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

6.  L-glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats.

Authors:  Sachin L Badole; Ganesh B Jangam; Swapnil M Chaudhari; Arvindkumar E Ghule; Anand A Zanwar
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

7.  Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease.

Authors:  Zhihui Lin; Fangfang Cai; Ning Lin; Jinli Ye; Qiqi Zheng; Guisheng Ding
Journal:  Exp Ther Med       Date:  2013-12-04       Impact factor: 2.447

8.  Effect of estragole on leukocyte behavior and phagocytic activity of macrophages.

Authors:  Francielli Maria de Souza Silva-Comar; Luiz Alexandre Marques Wiirzler; Saulo Euclides Silva-Filho; Raquel Kummer; Raissa Bocchi Pedroso; Ricardo Alexandre Spironello; Expedito Leite Silva; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-23       Impact factor: 2.629

9.  Protective effects of l-glutamine against toxicity of deltamethrin in the cerebral tissue.

Authors:  Sefer Varol; Hasan Hüseyin Özdemir; Mehmet Uğur Çevik; Yaşar Altun; Ibrahim Ibiloğlu; Aysun Ekinci; Aslıhan Okan Ibiloğlu; Metin Balduz; Demet Arslan; Recep Tekin; Fesih Aktar; Mehmet Ufuk Aluçlu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-21       Impact factor: 2.570

10.  Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats.

Authors:  Carlos Vinicius D da Rosa; Silvia C S F Azevedo; Roberto B Bazotte; Rosane M Peralta; Nilza C Buttow; Maria Montserrat D Pedrosa; Vilma A F de Godoi; Maria Raquel M Natali
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.